A US private equity firm has acquired a significant stake in the management of NHS patient records, prompting widespread concern among healthcare professionals and politicians. TPG's £300m purchase of Optum UK, which includes EMIS, means a private entity now controls the electronic patient record system utilised by more than half of GP practices across England. This acquisition positions TPG as a central player in handling the sensitive health data of millions of UK citizens.
The deal has been met with considerable criticism over the perceived lack of public oversight. Campaign groups, including Doctors' Association UK (DAUK), have voiced alarm, stating that the transfer of control for such critical infrastructure occurred without adequate scrutiny. They highlight that the business model of private equity firms prioritises investor returns, raising questions about the implications for patient care and data security. Liberal Democrats' health spokesperson, Helen Morgan MP, echoed these sentiments, suggesting such transactions are being 'rubber-stamped' without necessary protections for patients and calling for government support for British tech companies instead.
Further concerns have emerged regarding TPG's international operations. An investigation earlier this year by the International Consortium of Investigative Journalists (ICIJ) scrutinised hospitals in Kenya linked to Evercare, a healthcare group supported by TPG's Rise Fund. The investigation reported allegations of patients being burdened with substantial debts and, in some instances, required to offer land deeds as collateral for unpaid medical bills. TPG has strongly refuted these claims, asserting that it has invested significantly in Evercare to improve quality, accessibility, and patient rights, and that any suggestion of prioritising profits over patients is incorrect.
Anna Marriott, former Oxfam health policy lead, described the deal as a 'major alarm bell'. She emphasised the deep concern surrounding a private equity firm with a controversial international healthcare track record gaining control of sensitive NHS data with minimal public scrutiny. Marriott underscored that NHS patients have no input on who manages their medical records, making it the government's responsibility to guarantee their safety. She argued that the rapid expansion of private equity's involvement in the health service is outpacing the necessary regulatory safeguards to protect patients, healthcare workers, and the broader public interest.
EMIS, a key component of Optum UK, has a longstanding relationship with the NHS and the wider UK healthcare system. A spokesperson for EMIS affirmed their commitment to data security and patient privacy, stating these principles are fundamental to their operations, supported by rigorous controls. However, the acquisition by TPG has intensified calls for the government to clearly outline existing safeguards, explain the protocols for data handling if TPG were to resell the asset, and justify why this significant transfer of control was not debated in Parliament.